Dr. David Wasef, MD
Internal Medicine Physician · Wasef Health Group
Thoughtful, evidence-based telemedicine care with a focus on patient education, continuity, and long-term health.
GLP-1 Medical Weight Management
Ondra Health
Licensed provider review, transparent pricing, and pharmacy fulfillment based on your prescription and state.
WHAT IS ONDRA HEALTH
Ondra Health is a LegitScript-certified telehealth practice offering compounded semaglutide from $96 per month and compounded tirzepatide from $142 per month, with care from licensed providers through Wasef Health, PC.
Every plan includes your provider consultation, medication, supplies, and free shipping. No membership fee.
The same price applies across every titration dose within a plan.
| Plan* | Semaglutide | Tirzepatide |
|---|---|---|
| Monthly Billed every month | $149/mo $149 billed monthly | $219/mo $219 billed monthly |
| 3 months Most popular Billed quarterly | $113/mo $339 billed quarterly | $183/mo $549 billed quarterly |
| 6 months Billed up front | $108/mo $649 billed up front | $167/mo $999 billed up front |
| 12 months Billed up front | $96/mo $1,149 billed up front | $142/mo $1,699 billed up front |
Availability varies by state. Which plan lengths you can choose depends on the pharmacy licensed to serve your state. Check your state →
* Monthly and 3-month plans are available through all pharmacy partners. 6-month and 12-month plans are available only through Hallandale Pharmacy and Vials RX. Patients select a preferred pharmacy from the eligible options available for their state and medication. Pharmacy and formulation availability depends on state requirements, the prescription and current pharmacy inventory.
Compounded medications are not FDA-approved. Prescriptions are issued at provider discretion through Wasef Health, PC (Medical Director: David Wasef, MD). Medications are prepared by state-licensed 503A and 503B compounding pharmacies. The lowest per-month prices reflect the 6- and 12-month plans, billed in full up front.
We listen before we prescribe. Every treatment plan begins with understanding your story, your goals, and your life.
Licensed providers review every case personally. No automated approvals — just thoughtful, evidence-based care.
You're never alone in this. Our care team checks in regularly to adjust your plan and celebrate your progress.
We partner exclusively with state-licensed 503A and 503B-registered compounding pharmacies that meet the highest safety and quality standards.
Our network of independent licensed providers is authorized to treat patients across every state — so care is always within reach.
Treatments
Two proven options, each tailored by your provider to match your unique health profile.
Billed monthly · Same price on all doses
Select Pharmacy
Check availability in your area
Billed monthly · Same price on all doses
Select Pharmacy
Check availability in your area
*Compounded medications are not FDA-approved. Prepared by state-licensed pharmacies under Section 503A or 503B. Prescribed solely at the discretion of an independent, licensed healthcare provider. Same price applies across all titration doses within a plan.
See your potential
Enter your details below to estimate your BMI and how much weight you could lose on a GLP-1 program.
Check your BMI
Enter your height and weight below
Body Mass Index (BMI) is a measurement tool that uses your height and weight to estimate if your weight is in a healthy range for your height.*
Weight Loss Estimator
See your potential results with GLP-1
*Clinical estimates only. Individual results vary. Not medical advice.
The Process
Simple, transparent, and designed around your comfort.
A short health intake — no appointments, no waiting rooms. Takes a few minutes and a licensed provider reviews your profile personally.
Current weight
Height
Health goal
If you're a fit for treatment, your provider issues a prescription and your compounded medication ships directly to your door — free.
Semaglutide 0.25mg
Compounded · 503B Pharmacy
Ongoing check-ins, real provider messaging, and dose adjustments at every milestone. Your care doesn't stop at delivery.
0.25mg
Starting dose · Wk 1
Illustrative purposes only. All names, messages, and outcomes shown are fictional and do not represent real patients or results. Individual results not guaranteed.
Wasef Health Group
All physicians featured here are part of Wasef Health Group. Every intake is reviewed by a licensed, board-certified physician, and providers are licensed in all 50 states.
Internal Medicine Physician · Wasef Health Group
Thoughtful, evidence-based telemedicine care with a focus on patient education, continuity, and long-term health.
Internal Medicine Physician · Wasef Health Group
NPI 1417261926
Founder of Wasef Health Group, supporting Ondra Health's provider network with a focus on safe, compliant, patient-centered virtual care.
Family Medicine Physician · Wasef Health Group
NPI 1740576925
Patient-centered care across a wide range of health needs, with a practical, well-rounded family medicine approach.
Family Medicine Physician · Wasef Health Group
NPI 1700199213
Compassionate, accessible telemedicine care with clear communication and a background across multiple telehealth platforms.
What the clinical research shows
Below are peer-reviewed findings from the pivotal trials of the branded, FDA-approved GLP-1 medications. Compounded medications have not been studied in these trials, and individual results vary.
Average body-weight reduction with semaglutide
Adults with overweight or obesity taking once-weekly semaglutide 2.4 mg plus lifestyle support lost an average of 14.9% of their body weight over 68 weeks, versus 2.4% on placebo.
STEP-1 · Wilding et al., NEJM 2021. Finding for the FDA-approved product studied (Wegovy®).
Average body-weight reduction with tirzepatide
On the 15 mg dose, adults with obesity or overweight taking once-weekly tirzepatide plus lifestyle support lost an average of up to 22.5% of their body weight over 72 weeks, versus 2.4% on placebo.
SURMOUNT-1 · Jastreboff et al., NEJM 2022. Finding for the FDA-approved product studied (Zepbound®).
Reached 20%+ weight loss on tirzepatide
In the same trial, 57% of participants on the 15 mg tirzepatide dose achieved a body-weight reduction of 20% or more — a degree of weight loss the study authors described as unusually substantial for an obesity medication.
SURMOUNT-1 · Jastreboff et al., NEJM 2022. Finding for the FDA-approved product studied (Zepbound®).
The results above are from clinical trials of the branded, FDA-approved versions of semaglutide (Wegovy®) and tirzepatide (Zepbound®). Ondra Health provides access to compounded semaglutide and tirzepatide, which are not FDA-approved, are not therapeutically equivalent to the branded products, and have not been evaluated in these trials. Individual results vary based on health profile, adherence, and lifestyle. All prescribing decisions are made solely by independent, licensed healthcare providers.
Support
Everything you need to know about Ondra, your treatment, and how it all works.
Browse all FAQsHow Ondra Works
Looking for more detail?
View the full FAQ pageStill have questions?
Send us a messageWelcome to Ondra · $15 off your first 3 Month Tirzepatide Plan · use
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.